Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ONC stock hub

BeOne Medicines AG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ONCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

34.7B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ONC

In the news

Latest news · ONC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E45

P25 12.3P50 18.4P75 33.1

Trailing P/E70.9

P25 14.9P50 23.2P75 38.5

ROE12.4

P25 -105.6P50 -46.5P75 -3.1

ROIC53.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ONC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001651308
Company name	BeOne Medicines AG
Country	Switzerland
Country code	US
Employees	12,000
Employees Change	1,000%
Employees Change Percent	9.09
Enterprise value	$31.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US07725L1026
Last refreshed	2026-05-10
Market cap	$34.7B
Market cap category	Large-Cap
Price	$312
Price currency	USD
Rev Per Employee	478,266x
Sector	Healthcare
Sic	2834
Symbol	ONC
Website	https://beonemedicines.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.48%
EV Earnings	60.54x
EV/EBIT	45.28x
EV/EBITDA	37.63x
EV/FCF	27.86x
EV/Sales	5.41x
FCF yield	3.21%
Forward P/E	44.99x
P/B ratio	7.29x
P/E ratio	70.87x
P/S ratio	6.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.95%
EBITDA Margin	14.38%
FCF margin	19.42%
Gross margin	88.31%
Gross Profit	$5.1B
Gross Profit Growth	43.11%
Gross Profit Growth Q	41.37%
Gross Profit Growth3 Y	45.54%
Net Income	$513M
Net Income Growth Q	17,802.13%
Net Income Growth Quarters	6%
Net Income Growth Years	3%
Pretax Margin	11.42%
Profit Margin	8.94%
Profit Per Employee	$42,752
Profitable Years	1
ROA	5.96
Roa5y	-8.44
ROCE	10.17
ROE	12.42
Roe5y	-20.17
ROIC	53.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	28.1%
Cagr1y	34.42%
Cagr3y	7.71%
Cagr5y	0.01%
EPS Growth Q	16,970.8
EPS Growth Years	3
OCF Growth	505.99%
OCF Growth Q	356.73%
Revenue Growth	37.44x
Revenue Growth Q	35.46x
Revenue Growth Quarters	16x
Revenue Growth Years	5x
Revenue Growth3 Y	54.47x
Revenue Growth5 Y	46.08x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.8
Assets	$8.6B
Cash	$4.8B
Current Assets	$6.6B
Current Liabilities	$1.8B
Debt	$1.1B
Debt EBITDA	$1.34
Debt Equity	$0.24
Debt FCF	$1.03
Equity	$4.8B
Interest Coverage	8.15
Liabilities	$3.8B
Long Term Assets	$2B
Long Term Liabilities	$2B
Net Cash	$3.6B
Net Cash By Market Cap	$10.5
Net Cash Growth	139.72%
Net Debt EBITDA	$-4.41
Net Debt Equity	$-0.77
Net Debt FCF	$-3.27
Tangible Book Value	$4.7B
Tangible Book Value Per Share	$42.29
WACC	6.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.64
Inventory Turnover	1.14
Net Working Capital	$134.8M
Quick ratio	3.17
Working Capital	$4.8B
Working Capital Turnover	$1.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.16%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,089.48%
1Y total return	34.39%
200-day SMA	320.9
3Y total return	24.95%
50-day SMA	299.8
50-day SMA vs 200-day SMA	50under200
5Y total return	0.05%
All Time High	426.6
All Time High Change	-26.83%
All Time High Date	2021-09-17
All Time Low	22.51
All Time Low Change	1,286.58%
All Time Low Date	2016-02-11
ATR	8.55
Beta	0.5
Beta1y	0.5
Beta2y	0.75
Ch YTD	2.74
High	318.1
High52	385.2
High52 Date	2025-11-17
High52ch	-18.98%
Low	311.7
Low52	218.3
Low52 Date	2025-05-14
Low52ch	42.97%
Ma50ch	4.12%
Premarket Change Percent	-0.44
Premarket Price	$316
Premarket Volume	685
Price vs 200-day SMA	-2.73%
RSI	55.66
RSI Monthly	57.26
RSI Weekly	50.05
Sharpe ratio	0.83x
Sortino ratio	1.41
Total Return	-8.16%
Tr YTD	2.74
Tr1m	2.73%
Tr1w	6.21%
Tr3m	-11.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	4
Analyst Price Target Top	$370
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.79
Earnings EPS Estimate Growth	-35.25
Earnings Revenue Estimate	1,440,996,728x
Earnings Revenue Estimate Growth	29.01x
Operating Income	$685.9M
Operating Income Growth Q	2,151
Operating margin	11.95
Price target	$388
Price Target Change	$24.25
Price Target Change Top	$18.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	78,053,286%
Float Percent	70.21%
Net Borrowing	151,500,000
Shares Insiders	4.43%
Shares Institutions	49.43%
Shares Out	111,174,026
Shares Qo Q	0.34%
Shares Yo Y	8.16%
Short Float	1.48%
Short Ratio	5.41
Short Shares	1.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$575.9M
Average Volume	217,097.45x
Bv Per Share	42.84
CAPEX	$-170.2M
Ch10y	1,089.5
Ch1m	2.73
Ch1w	6.21
Ch1y	34.39
Ch3m	-11.81
Ch3y	24.95
Ch5y	0.05
Ch6m	-2.45
Change	-1.54%
Change From Open	-1.54
Close	317
Days Gap	0
Depreciation Amortization	139,453,000
Dollar Volume	65,660,684.4
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$685.9M
EBITDA	$825.4M
EPS	$4.4
F Score	7
FCF	$1.1B
FCF EV Yield	3.59x
FCF Per Share	$10.03
Financing CF	1,161,860,000
Fiscal Year End	December
Founded	2,010
Graham Number	66.67741
Graham Upside	-78.64
Income Tax	$142.1M
Investing CF	-199,724,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	322.1
Ma150ch	-3.09%
Ma20	306.9
Ma20ch	1.71%
Net CF	2,322,834,000
Next Earnings Date	2026-08-05
Open	317
Optionable	Yes
P FCF Ratio	31.13
P OCF Ratio	27.01
Position In Range	7.19
Post Close	312.1
Postmarket Change Percent	-3.41
Postmarket Price	$301
Ppne	1,786,415,000
Pre Close	317
Price Date	2026-05-08
Price EBITDA	$42.04
Ptbv Ratio	7.38
Relative Volume	0.97x
Revenue	5,739,192,000x
SBC By Revenue	9.39x
Share Based Comp	538,734,000
Tax By Revenue	2.48x
Tax Rate	21.7%
Tr6m	-2.45%
Volume	210,370
Z Score	5.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ONC pay a dividend?

Capital-return profile for this ticker.

Performance

ONC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ONC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+49.4%

Float: +70.2% of shares outstanding

Insider ownership

+4.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ONC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.7

Neutral momentum band

Price vs 200-day MA

-2.7%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ONC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ONC stock rating?

BeOne Medicines AG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ONC analysis?

The full report lives at /stocks/ONC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ONC?

The latest report frames ONC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ONC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.